Taysha Gene Therapies Stock Down 1.7 % Shares of NASDAQ:TSHA opened at $1.72 on Tuesday. The company has a current ratio of 5.51, a quick ratio of 5.51 and a debt-to-equity ratio of 0.48. The ...

In this article, we will see how Taysha Gene Therapies, Inc. (NASDAQ:TSHA) compares to the other top short squeeze stocks that have received a Buy rating from analysts. Stock market trading has an ...

TSHA opened at $1.72 on Tuesday. The firm has a market cap of $352.60 million, a price-to-earnings ratio of 2.73 and a beta of 0.91. Taysha Gene Therapies has a 52 week low of $1.19 and a 52 week ...

Taysha Gene Therapies, Inc. (TSHA) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.35 per share a year ago.

We recently shared a list of 10 Best Short Squeeze Stocks To Buy According to Analysts. In this article, we will see how Taysha Gene Therapies, Inc. (NASDAQ:TSHA) compares to the other top short ...

High dose and low dose of TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in all pediatric, adolescent and adult patients treated (high dose, n=6 ...

If you’re craving rich, creamy chocolate fudge but don’t want to spend hours in the kitchen, Paula Deen’s 5-Minute Fudge is ...